Israel Englander Viking Therapeutics, Inc. Put Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$47.39 - $80.2 $549,724 - $930,320
11,600 New
11,600 $614,000
Q2 2023

Aug 14, 2023
SELL
$14.84 - $24.79 $2.79 Million - $4.66 Million
-188,000 Reduced 81.39%
43,000 $697,000
Q1 2023

May 15, 2023
BUY
$8.08 - $17.33 $1.54 Million - $3.31 Million
191,000 Added 477.5%
231,000 $3.85 Million
Q4 2022

Feb 14, 2023
BUY
$2.72 - $9.4 $108,800 - $376,000
40,000 New
40,000 $376,000

Others Institutions Holding VKTX

# of Institutions
442
Shares Held
63.3M
Call Options Held
6.23M
Put Options Held
2.97M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.73B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email